133 related articles for article (PubMed ID: 11407306)
1. Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system.
Hedlund G; Link H; Zhu J; Xiao BG
Int Immunopharmacol; 2001 Jun; 1(6):1123-30. PubMed ID: 11407306
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus.
Gross DJ; Weiss L; Reibstein I; Hedlund G; Dahlén E; Rapoport MJ; Slavin S
Int Immunopharmacol; 2001 Jun; 1(6):1131-9. PubMed ID: 11407307
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Ben-Nun A; Kalland T; Abramsky O
Ann Neurol; 1993 Nov; 34(5):654-60. PubMed ID: 8239559
[TBL] [Abstract][Full Text] [Related]
4. Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis.
Tian WZ; Navikas V; Matusevicius D; Söderström M; Fredrikson S; Hedlund G; Link H
Acta Neurol Scand; 1998 Aug; 98(2):94-101. PubMed ID: 9724006
[TBL] [Abstract][Full Text] [Related]
5. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.
Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H
Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420
[TBL] [Abstract][Full Text] [Related]
6. Linomide, an immunomodulator that inhibits Th1 cytokine gene expression.
Arad G; Katzenellenbogen M; Levy R; Slavin S; Kaempfer R
Int Immunol; 1996 Oct; 8(10):1603-7. PubMed ID: 8921440
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis.
Lehmann D; Karussis DM; Fluresco D; Mizrachi-Koll R; Ovadia H; Shezen E; Kalland T; Abramsky O
J Neuroimmunol; 1997 Apr; 74(1-2):102-10. PubMed ID: 9119961
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Kalland T; Abramsky O
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6400-4. PubMed ID: 8341645
[TBL] [Abstract][Full Text] [Related]
9. Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions.
Bai XF; Shi FD; Zhu J; Xiao BG; Hedlund G; Link H
J Neuroimmunol; 1997 Jun; 76(1-2):177-84. PubMed ID: 9184648
[TBL] [Abstract][Full Text] [Related]
10. Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes.
Karussis D; Abramsky O; Rosenthal Y; Mizrachi-Koll R; Ovadia H
Immunol Lett; 1999 Apr; 67(3):203-8. PubMed ID: 10369127
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functions.
Shirkey BL; Slavin S; Vistica BP; Podgor MJ; Gery I
Clin Exp Immunol; 1997 Jun; 108(3):539-44. PubMed ID: 9182904
[TBL] [Abstract][Full Text] [Related]
12. Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines.
Diab A; Michael L; Wahren B; Deng GM; Björk J; Hedlund G; Zhu J
J Neuroimmunol; 1998 May; 85(2):146-54. PubMed ID: 9630163
[TBL] [Abstract][Full Text] [Related]
13. The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice.
Morecki S; Nabet C; Falk P; Fridkis-Hareli M; Pecht I; Mond JJ; Slavin S
Autoimmunity; 1997; 25(4):223-32. PubMed ID: 9344330
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice.
Björk J; Kleinau S
Agents Actions; 1989 Jun; 27(3-4):319-21. PubMed ID: 2801316
[TBL] [Abstract][Full Text] [Related]
15. Selective downregulation of Th1 response by Linomide reduces autoimmunity but increases susceptibility to viral infection in BALB/c and SJL mice.
Erälinna JP; Röyttä M; Hukkanen V; Zinhu D; Salmi AA; Salonen R
J Neuroimmunol; 1998 Aug; 88(1-2):165-76. PubMed ID: 9688338
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production in Linomide-treated nod mice and the potential role of a Th (1)/Th(2) shift on autoimmune and anti-inflammatory processes.
Weiss L; Barak V; Zeira M; Abdul-Hai A; Raibstein I; Reich S; Hirschfeld E; Gross D; Slavin S
Cytokine; 2002 Jul; 19(2):85-93. PubMed ID: 12182843
[TBL] [Abstract][Full Text] [Related]
17. Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats.
Zhu J; Diab A; Mustafa M; Levi M; Wahren B; Björk J; Hedlund G
J Neurol Sci; 1998 Oct; 160(2):113-20. PubMed ID: 9849793
[TBL] [Abstract][Full Text] [Related]
18. Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis.
Drescher KM; Rivera-Quinones C; Lucchinetti CF; Rodriguez M
J Neuroimmunol; 1998 Aug; 88(1-2):111-9. PubMed ID: 9688332
[TBL] [Abstract][Full Text] [Related]
19. The immune modulator Linomide prevents neuronal death in injured peripheral nerves of the mouse.
Ekström PA; Hedlund G; Karlsson J; Andersson G
Neuroreport; 1998 May; 9(7):1337-41. PubMed ID: 9631425
[TBL] [Abstract][Full Text] [Related]
20. Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation.
Karussis DM; Meiner Z; Lehmann D; Gomori JM; Schwarz A; Linde A; Abramsky O
Neurology; 1996 Aug; 47(2):341-6. PubMed ID: 8757002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
